Cell & Gene Therapy

  1. SK pharmteco Capacity Update April 2025: Analytical Services 4/22/2025

    Get the quality, compliance, and accelerated development support you need for your small molecule and cell and gene therapy program with our advanced analytical testing services.

  2. cGMP-Ready Clonal HEK293 Cell Line For AAV, Lenti-, And Adenoviral Vectors 11/7/2024

    See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

  3. Advancing Viral Vector Manufacturing: The Importance Of The Cell Line 9/16/2024

    Explore the pivotal role of cell lines in viral vector manufacturing, a complex, multi-step process that has traditionally been both time-consuming and labor-intensive.

  4. A Platform Approach To Accelerating Advanced Therapy Development And Manufacturing 9/16/2024

    Explore strategies for integrating cutting-edge technologies and optimizing unit operations to expedite the development and manufacturing of cell and gene therapies.

  5. Development Of A Universal, GMP-Ready, Clonal HEK293 Cell Line 9/16/2024

    When manufacturing adeno-associated virus, lenti- and adenoviral vectors, see how this HEK293 cell line is optimized for suspension culture and viral vector production, which can significantly reduce costs.